Nasdaq: RXRX | |
Founded | 2013 |
Headquarters |
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering.[1][2][3]
The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.[4][5]
:0
was invoked but never defined (see the help page).